Astromech Raises $20M to Build a Biological Operating System for Forecasting Evolutionary Change

Astromech has closed a $20 million funding round to develop what it describes as a biological operating system — an AI platform designed to model and forecast evolutionary change in biological systems. The company's approach targets applications in drug discovery, synthetic biology, and evolutionary genomics by treating biological dynamics as a computable, predictable system. For AI developers adjacent to life sciences, this represents an emerging category of domain-specific foundation models trained on biological sequence and phenotype data. The funding signals continued investor appetite for AI platforms that go beyond general-purpose LLMs into deeply specialized scientific domains. Developers with ML expertise looking to apply skills in high-value vertical markets should watch this space as a leading indicator of where specialized AI investment is flowing.